Anatoli S Gleiberman (Anatoli Gleiberman)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Health Risk Assessment

Inflammatory Response

Acinetobacter Baumannii

Lipopolysaccharide Induced

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Cancer research communications

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Alexandra V Vylegzhanina, Ivan Bespalov, Ksenia Novototskaya-Vlasova, Brandon M Hall, Anatoli S Gleiberman, Han Yu, Olga Leontieva, Katerina I Leonova, Oleg Kurnasov, Andrei L Osterman, Grace K Dy, Alexey A Komissarov, Elena J Vasilieva, Jeffrey R Gehlhausen, Akiko Iwasak, Christine B Ambrosone, Takemasa Tsuji, Junko Matsuzaki, Kunle Odunsi, Ekaterina Andrianova, Andrei V Gudkov
Cancer relevance of circulating antibodies against LINE-1 antigens in humans. Cancer research communications (2023)
Ksenia A Novototskaya-Vlasova, Nickolay S Neznanov, Ivan Molodtsov, Brandon M Hall, Mairead Commane, Anatoli S Gleiberman, Jayne Murray, Michelle Haber, Murray D Norris, Katerina I Leonova, Andrei V Gudkov
Inflammatory response to retrotransposons drives tumor drug resistance that can be prevented by reverse transcriptase inhibitors. Proceedings of the National Academy of Sciences of the United States of America 119 (49) (2022)
Natalia Fedtsova, Elena A Komarova, Kellee F Greene, Liliya R Novototskaya, Ivan Molodtsov, Craig M Brackett, Evguenia Strom, Anatoli S Gleiberman, Alexander N Shakhov, Andrei V Gudkov
Resistance of bone marrow stroma to genotoxic preconditioning is determined by p53. Cell death & disease 12 (6) (2021)